Immunomic Therapeutics logo

Immunomic Therapeutics

25 people · 0 jobs

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.

Industries

Employees

11-50

Links


Org chart


Board & advisors


Teams


Offices